re: News: Biotron's Hep C drug candidate phas... It would not surprise me to see a sudden trading halt followed by an announcement that the company has entered an agreement with a major pharmaceutical to fund phase III trials with BIT225. There would also be a project to fast track studies into patients infected with both HIV and HCV.
If this happens the opportunity to invest at these low levels will be lost.
GL to all
Regards
Will
News: Biotron's Hep C drug candidate phase 2a tri, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $6.369K | 330.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 847148 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1129029 | 5 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |